Fortschritte in der Pharmakotherapie
作者： Timothy E. Wilens , Ralf W. Dittmann
DOI: 10.1007/978-3-642-92473-6_7
关键词:
摘要: Neben der Beratung und den psychosozialen Interventionen nimmt die Pharmakotherapie im multimodalen Therapiekonzept von ADS/ADHS eine zentrale Rolle ein. Derzeit gelten Stimulanzien wie Methylphenidat als Mittel Wahl. Neue medikamentose Optionen Atomoxetin versprechen zukunftig moglicherweise Fortschritte in Behandlung ADS/ADHS.
springer.com
sci-hub.st 参考文章(15)
Charles E. Cunningham, Linda S. Siegel, David R. Offord, A developmental dose-response analysis of the effects of methylphenidate on the peer interactions of attention deficit disordered boys. Journal of Child Psychology and Psychiatry. ,vol. 26, pp. 955- 971 ,(1985) , 10.1111/J.1469-7610.1985.TB00609.X
Jefferson B. Prince, Timothy E. Wilens, Joseph Biederman, Thomas J. Spencer, Rachael Millstein, David A. Polisner, Jeff Q. Bostic, A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. ,vol. 10, pp. 193- 204 ,(2000) , 10.1089/10445460050167304
CHRISTOPHER J. KRATOCHVIL, JOHN H. HEILIGENSTEIN, RALF DITTMANN, THOMAS J. SPENCER, JOSEPH BIEDERMAN, JOACHIM WERNICKE, JEFFREY H. NEWCORN, CHARLES CASAT, DENÁI MILTON, DAVID MICHELSON, Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. Journal of the American Academy of Child and Adolescent Psychiatry. ,vol. 41, pp. 776- 784 ,(2002) , 10.1097/00004583-200207000-00008
ROBERT D. HUNT, RUUD B. MINDERAA, DONALD J. COHEN, Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. Journal of The American Academy of Child Psychiatry. ,vol. 24, pp. 617- 629 ,(1985) , 10.1016/S0002-7138(09)60065-0
Thomas Spencer, Joseph Biederman, Timothy Wilens, Jeffry Prince, Mary Hatch, Janice Jones, Margaret Harding, Stephen V. Faraone, Larry Seidman, Effectiveness and Tolerability of Tomoxetine in Adults With Attention Deficit Hyperactivity Disorder American Journal of Psychiatry. ,vol. 155, pp. 693- 695 ,(1998) , 10.1176/AJP.155.5.693
Timothy E. Wilens, Thomas J. Spencer, Joseph Biederman, Kristine Girard, Robert Doyle, Jefferson Prince, David Polisner, Ramon Solhkhah, Sharyn Comeau, Michael C. Monuteaux, Asha Parekh, A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults American Journal of Psychiatry. ,vol. 158, pp. 282- 288 ,(2001) , 10.1176/APPI.AJP.158.2.282
D. Michelson, D. Faries, J. Wernicke, D. Kelsey, K. Kendrick, F. R. Sallee, T. Spencer, the Atomoxetine ADHD Study Group, Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. ,vol. 108, ,(2001) , 10.1542/PEDS.108.5.E83
David Michelson, Albert J. Allen, Joan Busner, Charles Casat, David Dunn, Christopher Kratochvil, Jeffrey Newcorn, F. Randy Sallee, R. Bart Sangal, Keith Saylor, Scott West, Douglas Kelsey, Joachim Wernicke, Nancy J. Trapp, Donald Harder, Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study American Journal of Psychiatry. ,vol. 159, pp. 1896- 1901 ,(2002) , 10.1176/APPI.AJP.159.11.1896
T. E. Wilens, S. V. Faraone, J. Biederman, S. Gunawardene, Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. ,vol. 111, pp. 179- 185 ,(2003) , 10.1542/PEDS.111.1.179
Russell A Barkley, Russell A Barkley, Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment ,(2005)